CME Group Inc. $CME Stock Holdings Raised by Kornitzer Capital Management Inc. KS

Kornitzer Capital Management Inc. KS lifted its holdings in CME Group Inc. (NASDAQ:CME) by 5.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 46,080 shares of the financial services provider’s stock after purchasing an additional 2,409 shares during the period. Kornitzer Capital Management Inc. KS’s holdings in CME Group were worth $12,072,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently bought and sold shares of the business. BlackRock Inc. purchased a new position in CME Group during the second quarter worth approximately $6,749,965,000. Bank of New York Mellon Corp acquired a new stake in CME Group in the second quarter valued at approximately $867,313,000. Alphabet Inc. acquired a new stake in CME Group in the second quarter valued at approximately $769,376,000. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in shares of CME Group in the second quarter valued at approximately $629,771,000. Finally, Bank of America Corp DE purchased a new stake in shares of CME Group in the second quarter valued at approximately $622,679,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Buying and Selling at CME Group

In other news, insider Sunil Cutinho sold 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, October 27th. The stock was sold at an average price of $298.70, for a total value of $1,493,500.00. Following the transaction, the insider owned 20,037 shares in the company, valued at $5,985,051.90. This trade represents a 19.97% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Terrence Duffy sold 15,000 shares of CME Group stock in a transaction that occurred on Thursday, September 10th. The stock was sold at an average price of $274.44, for a total value of $4,116,600.00. Following the completion of the sale, the chief executive officer directly owned 40,630 shares in the company, valued at $11,150,497.20. This represents a 26.96% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 32,979 shares of company stock valued at $9,552,762. 0.30% of the stock is owned by insiders.

CME Group Stock Down 0.4%

CME opened at $305.89 on Friday. The company has a market cap of $109.49 billion, a PE ratio of 25.09, a price-to-earnings-growth ratio of 3.73 and a beta of 0.15. CME Group Inc. has a twelve month low of $218.31 and a twelve month high of $329.16. The company has a 50-day moving average price of $283.10 and a 200 day moving average price of $280.79. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.99 by $0.03. CME Group had a return on equity of 16.23% and a net margin of 63.33%. The company had revenue of $1.74 billion for the quarter, compared to analysts’ expectations of $1.71 billion. During the same period in the previous year, the firm posted $2.68 EPS. CME Group’s revenue was up 10.6% compared to the same quarter last year. Sell-side analysts expect that CME Group Inc. will post 12.34 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 30th. Shareholders of record on Friday, December 11th will be issued a dividend of $1.30 per share. The ex-dividend date of this dividend is Friday, December 11th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.7%. CME Group’s dividend payout ratio is presently 42.66%.

Analysts Set New Price Targets

CME has been the subject of several research analyst reports. CLSA set a $367.00 target price on CME Group in a research note on Thursday, October 22nd. Morgan Stanley increased their target price on CME Group from $337.00 to $359.00 and gave the company an “overweight” rating in a research report on Thursday, October 22nd. Piper Sandler reissued an “overweight” rating and issued a $330.00 price target (up from $295.00) on shares of CME Group in a research note on Thursday, October 22nd. Barclays boosted their price target on shares of CME Group from $281.00 to $321.00 and gave the stock an “equal weight” rating in a report on Thursday, October 22nd. Finally, JPMorgan Chase & Co. raised shares of CME Group from an “underweight” rating to an “overweight” rating and set a $367.00 price target for the company in a report on Thursday, October 22nd. Ten research analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, CME Group presently has an average rating of “Hold” and a consensus target price of $314.44.

CME Group Company Profile

CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals.

The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.

CME Group was formed in 2007 through the merger of the Chicago Mercantile Exchange and the Chicago Board of Trade, institutions with roots in the 19th century.